Posted by Michael Wonder on 25 Jan 2021
EMA publishes agenda for 25-29 January CHMP meeting
25 January 2021 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Bevacizumab
- Salmeterol xinafoate with fluticasone propionate
- Remimazolam
- Dostarlimab
- Ofatumumab acetate
- Selinexor
- Cenobamate
- Pemigatinib
- Somapacitan
- Thiotepa
- Icosapent ethyl
- COVID-19 Vaccine (ChAdOx1-S [recombinant])
- Comirnaty - COVID-19 mRNA vaccine (nucleoside-modified)
- COVID-19 Vaccine Moderna – COVID-19 mRNA vaccine (nucleoside-modified)
Read CHMP agenda
Posted by:
Michael Wonder